| Behavioral Sciences | Histology and Cell Biology | Pathology | ||
| Biochemistry | Microbiology | Pharmacology | ||
| Gross Anatomy and Embryology | Neuroscience |
Physiology |
Content Outline and Sample Items for Subject Examinations with both PAPER AND WEB VERSIONS
| NEUROSCIENCE | ||
|---|---|---|
| Biology of cells (signal transduction, muscle cells) | 1%–5% |
|
| Central/peripheral nervous system | 95%–99% |
|
| Normal processes | 65%–70% |
|
| Embryonic development | 1%–5% |
|
| Organ structure and function | 50%–55% |
|
| Spinal cord | 5%–10% |
|
| Brain stem | 5%–10% |
|
| Brain | 5%–10% |
|
| Sensory systems | 5%–10% |
|
| Motor systems | 5%–10% |
|
| Autonomic nervous systems | 1%–5% |
|
| Peripheral nerve | 1%–5% |
|
| Cell/tissue structure and function | 5%–10% |
|
| Repair, regeneration, and changes associated with stage of life | 1%–5% |
|
| Abnormal processes | 25%–30% |
|
| Infectious, inflammatory, immunologic disorders | 1%–5% |
|
| Traumatic/mechanical disorders | 1%–5% |
|
| Neoplastic disorders | 1%–5% |
|
| Metabolic/regulatory disorders | 1%–5% |
|
| Vascular disorders | 1%–5% |
|
| Systemic disorders | 1%–5% |
|
| Idiopathic disorders | 1%–5% |
|
| Congenital/metabolic disorders | 1%–5% |
|
| Degenerative disorders | 1%–5% |
|
| Paroxysmal disorders | 1%–5% |
|
| Disorders of the special senses | 1%–5% |
|
| Principles of therapeutics | 1%–5% |
|
| NEUROPATHOLOGY | ||
| Nutrition | 1%–5% |
|
| Central/peripheral nervous system | 95%–99% |
|
| Infectious, inflammatory, immunologic disorders | 20%–25% |
|
| Traumatic/mechanical disorders | 1%–5% |
|
| Neoplastic disorders | 20%–25% |
|
| Vascular disorders | 15%–20% |
|
| Congenital/metabolic disorders | 5%–10% |
|
| Degenerative disorders | 20%–25% |
|
| PSYCHOPATHOLOGY/PSYCHOPHARMACOLOGY | ||
| Personality traits or coping style | 1%–5% |
|
| Central/peripheral nervous system | 95%–99% |
|
| Psychopathologic disorders | 70%–75% |
|
| Early-onset disorders | 1%–5% |
|
| Substance use disorders | 10%–15% |
|
| Schizophrenia | 10%–15% |
|
| Mood disorders | 15%–20% |
|
| Anxiety disorders | 10%–15% |
|
| Somatoform disorders | 1%–5% |
|
| Physical and sexual abuse | 5%–10% |
|
| Other disorders | 1%–5% |
|
| Psychopharmacologic agents | 20%–25% |
|